Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Federated Hermes (FHI) Research & Development (2016 - 2025)

Federated Hermes' Research & Development history spans 17 years, with the latest figure at -$16.0 million for Q4 2025.

  • For Q4 2025, Research & Development fell 494.18% year-over-year to -$16.0 million; the TTM value through Dec 2025 reached $17.0 million, down 51.16%, while the annual FY2025 figure was $17.0 million, 10.47% up from the prior year.
  • Research & Development for Q4 2025 was -$16.0 million at Federated Hermes, down from $4.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $73.1 million in Q4 2023 and bottomed at -$30.9 million in Q3 2023.
  • The 5-year median for Research & Development is $4.4 million (2025), against an average of $11.1 million.
  • The largest annual shift saw Research & Development skyrocketed 5732.0% in 2021 before it tumbled 494.18% in 2025.
  • A 5-year view of Research & Development shows it stood at $19.3 million in 2021, then rose by 6.23% to $20.5 million in 2022, then soared by 255.74% to $73.1 million in 2023, then plummeted by 94.45% to $4.1 million in 2024, then crashed by 494.18% to -$16.0 million in 2025.
  • Per Business Quant, the three most recent readings for FHI's Research & Development are -$16.0 million (Q4 2025), $4.7 million (Q3 2025), and $4.1 million (Q2 2025).